387 results on '"Friedrich, Thomas C."'
Search Results
2. Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage
- Author
-
Shafer, Martin M, Bobholz, Max J, Vuyk, William C, Gregory, Devon A, Roguet, Adelaide, Haddock Soto, Luis A, Rushford, Clayton, Janssen, Kayley H, Emmen, Isla E, Ries, Hunter J, Pilch, Hannah E, Mullen, Paige A, Fahney, Rebecca B, Wei, Wanting, Lambert, Matthew, Wenzel, Jeff, Halfmann, Peter, Kawaoka, Yoshihiro, Wilson, Nancy A, Friedrich, Thomas C, Pray, Ian W, Westergaard, Ryan, O’Connor, David H, and Johnson, Marc C
- Published
- 2024
- Full Text
- View/download PDF
3. SARS-CoV-2 and other respiratory pathogens are detected in continuous air samples from congregate settings
- Author
-
Ramuta, Mitchell D., Newman, Christina M., Brakefield, Savannah F., Stauss, Miranda R., Wiseman, Roger W., Kita-Yarbro, Amanda, O’Connor, Eli J., Dahal, Neeti, Lim, Ailam, Poulsen, Keith P., Safdar, Nasia, Marx, John A., Accola, Molly A., Rehrauer, William M., Zimmer, Julia A., Khubbar, Manjeet, Beversdorf, Lucas J., Boehm, Emma C., Castañeda, David, Rushford, Clayton, Gregory, Devon A., Yao, Joseph D., Bhattacharyya, Sanjib, Johnson, Marc C., Aliota, Matthew T., Friedrich, Thomas C., O’Connor, David H., and O’Connor, Shelby L.
- Published
- 2022
- Full Text
- View/download PDF
4. Influenza A virus undergoes compartmentalized replication in vivo dominated by stochastic bottlenecks
- Author
-
Amato, Katherine A., Haddock, III, Luis A., Braun, Katarina M., Meliopoulos, Victoria, Livingston, Brandi, Honce, Rebekah, Schaack, Grace A., Boehm, Emma, Higgins, Christina A., Barry, Gabrielle L., Koelle, Katia, Schultz-Cherry, Stacey, Friedrich, Thomas C., and Mehle, Andrew
- Published
- 2022
- Full Text
- View/download PDF
5. Interventions to Disrupt Coronavirus Disease Transmission at a University, Wisconsin, USA, August-October 2020
- Author
-
Currie, Dustin W., Moreno, Gage K., Delahoy, Miranda J., Pray, Ian W., Jovaag, Amanda, Braun, Katarina M., Cole, Devlin, Shechter, Todd, Fajardo, Geroncio C., Griggs, Carol, Yandell, Brian S., Goldstein, Steve, Bushman, Dena, Segaloff, Hannah E., Kelly, G. Patrick, Pitts, Collin, Lee, Christine, Grande, Katarina M., Kita-Yarbro, Amanda, Grogan, Brittany, Mader, Sara, Baggott, Jake, Bateman, Allen C., Westergaard, Ryan P., Tate, Jacqueline E., Friedrich, Thomas C., Kirking, Hannah L., O'Connor, David H., and Killerby, Marie E.
- Subjects
Wisconsin -- Health aspects ,Epidemics -- Control -- Statistics -- United States ,Public universities and colleges -- Safety and security measures -- Health aspects ,Disease transmission -- Control ,Health ,University of Wisconsin -- Safety and security measures -- Health aspects - Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease (COVID-19), can spread rapidly within congregate settings, including institutions of higher education (IHEs) (1,2). During August-December 2020, as IHEs [...]
- Published
- 2021
- Full Text
- View/download PDF
6. Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2
- Author
-
Juang, Duane S., Juang, Terry D., Dudley, Dawn M., Newman, Christina M., Accola, Molly A., Rehrauer, William M., Friedrich, Thomas C., O’Connor, David H., and Beebe, David J.
- Published
- 2021
- Full Text
- View/download PDF
7. An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children
- Author
-
Florek, Kelsey R., Campos, Luiza M., Braun, Katarina M., McLean, Huong Q., King, Jennifer P., Flannery, Brendan, Belongia, Edward A., and Friedrich, Thomas C.
- Published
- 2018
- Full Text
- View/download PDF
8. Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread
- Author
-
Moreno, Gage K., Braun, Katarina M., Riemersma, Kasen K., Martin, Michael A., Halfmann, Peter J., Crooks, Chelsea M., Prall, Trent, Baker, David, Baczenas, John J., Heffron, Anna S., Ramuta, Mitchell, Khubbar, Manjeet, Weiler, Andrea M., Accola, Molly A., Rehrauer, William M., O’Connor, Shelby L., Safdar, Nasia, Pepperell, Caitlin S., Dasu, Trivikram, Bhattacharyya, Sanjib, Kawaoka, Yoshihiro, Koelle, Katia, O’Connor, David H., and Friedrich, Thomas C.
- Published
- 2020
- Full Text
- View/download PDF
9. Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques
- Author
-
Kiso, Maki, Iwatsuki-Horimoto, Kiyoko, Yamayoshi, Seiya, Uraki, Ryuta, Ito, Mutsumi, Nakajima, Noriko, Yamada, Shinya, Imai, Masaki, Kawakami, Eiryo, Tomita, Yuriko, Fukuyama, Satoshi, Itoh, Yasushi, Ogasawara, Kazumasa, Lopes, Tiago J. S., Watanabe, Tokiko, Moncla, Louise H., Hasegawa, Hideki, Friedrich, Thomas C., Neumann, Gabriele, and Kawaoka, Yoshihiro
- Published
- 2017
10. Using Virus Sequencing to Determine Source of SARS-CoV-2 Transmission for Healthcare Worker
- Author
-
Safdar, Nasia, Moreno, Gage K., Braun, Katarina M., Friedrich, Thomas C., and O'Connor, David H.
- Subjects
Severe acute respiratory syndrome -- Health aspects ,Coronaviruses -- Health aspects ,Cross infection -- Health aspects ,Disease susceptibility -- Health aspects ,Medical personnel -- Health aspects ,Infection control -- Health aspects ,COVID-19 -- Health aspects ,Health - Abstract
Healthcare workers (HCWs) are at the front lines of the coronavirus disease (COVID-19) pandemic; their interactions with patients and in the community put them at risk for infection with severe [...]
- Published
- 2020
- Full Text
- View/download PDF
11. Influenza Evolution: New Insights into an Old Foe
- Author
-
Moncla, Louise H., Florek, Kelsey R., and Friedrich, Thomas C.
- Published
- 2017
- Full Text
- View/download PDF
12. Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge.
- Author
-
Grunst, Michael W., Gil, Hwi Min, Grandea III, Andres G., Snow, Brian J., Andrabi, Raiees, Nedellec, Rebecca, Burton, Iszac, Clark, Natasha M., Janaka, Sanath Kumar, Keles, Nida K., Moriarty, Ryan V., Weiler, Andrea M., Capuano III, Saverio, Fennessey, Christine M., Friedrich, Thomas C., O'Connor, Shelby L., O'Connor, David H., Broman, Aimee T., Keele, Brandon F., and Lifson, Jeffrey D.
- Subjects
ANTIBODY-dependent cell cytotoxicity ,MONOCLONAL antibodies ,KILLER cells ,SIMIAN immunodeficiency virus ,MACAQUES ,FC receptors ,HIV - Abstract
Fc-mediated antibody effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), can contribute to the containment HIV-1 replication but whether such activities are sufficient for protection is unclear. We previously identified an antibody to the variable 2 (V2) apex of the HIV-1 Env trimer (PGT145) that potently directs the lysis of SIV-infected cells by NK cells but poorly neutralizes SIV infectivity. To determine if ADCC is sufficient for protection, separate groups of six rhesus macaques were treated with PGT145 or a control antibody (DEN3) by intravenous infusion followed five days later by intrarectal challenge with SIV
mac 239. Despite high concentrations of PGT145 and potent ADCC activity in plasma on the day of challenge, all animals became infected and viral loads did not differ between the PGT145- and DEN3-treated animals. To determine if PGT145 can protect against a neutralization-sensitive virus, two additional groups of six macaques were treated with PGT145 and DEN3 and challenged with an SIVmac 239 variant with a single amino acid change in Env (K180S) that increases PGT145 binding and renders the virus susceptible to neutralization by this antibody. Although there was no difference in virus acquisition, peak and chronic phase viral loads were significantly lower and time to peak viremia was significantly delayed in the PGT145-treated animals compared to the DEN3-treated control animals. Env changes were also selected in the PGT145-treated animals that confer resistance to both neutralization and ADCC. These results show that ADCC is not sufficient for protection by this V2-specific antibody. However, protection may be achieved by increasing the affinity of antibody binding to Env above the threshold required for neutralization. Author summary: Antibodies that bind to the human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) on virions can neutralize viral infectivity. Antibodies may also bind to Env on the surface of virus-infected cells and recruit immune cells to eliminate the productively infected cells through a process known as antibody dependent cellular cytotoxicity (ADCC). In rare instances, certain antibodies are capable of mediating ADCC despite negligible neutralizing activity. Such antibodies are thought to have contributed to the modest protection observed in the RV144 HIV-1 vaccine trial and in some nonhuman primate studies. One antibody, PGT145, was found to cross-react with simian immunodeficiency virus (SIV) and to mediate potent ADCC against SIV-infected cells despite weak neutralization of viral infectivity. We therefore tested if the potent ADCC activity of PGT145 could protect rhesus macaques against mucosal challenge with pathogenic SIV. PGT145 did not protect against wild-type SIVmac 239, but did protect against an SIVmac 239 variant with a single amino acid substitution in Env (K180S) that increases antibody binding to Env and makes the virus susceptible to neutralization. Thus, while ADCC may contribute to protection against immunodeficiency viruses through the elimination of productively infected cells, the higher affinity of Env binding necessary for potent neutralization is a critical determinant of antibody-mediated protection. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
13. Miscarriage and stillbirth following maternal Zika virus infection in nonhuman primates
- Author
-
Dudley, Dawn M., Van Rompay, Koen K., Coffey, Lark L., Ardeshir, Amir, Keesler, Rebekah I., Bliss-Moreau, Eliza, Grigsby, Peta L., Steinbach, Rosemary J., Hirsch, Alec J., MacAllister, Rhonda P., Pecoraro, Heidi L., Colgin, Lois M., Hodge, Travis, Streblow, Daniel N., Tardif, Suzette, Patterson, Jean L., Tamhankar, Manasi, Seferovic, Maxim, Aagaard, Kjersti M., Martín, Claudia Sánchez-San, Chiu, Charles Y., Panganiban, Antonito T., Veazey, Ronald S., Wang, Xiaolei, Maness, Nicholas J., Gilbert, Margaret H., Bohm, Rudolf P., Adams Waldorf, Kristina M., Gale, Jr, Michael, Rajagopal, Lakshmi, Hotchkiss, Charlotte E., Mohr, Emma L., Capuano, III, Saverio V., Simmons, Heather A., Mejia, Andres, Friedrich, Thomas C., Golos, Thaddeus G., and O’Connor, David H.
- Published
- 2018
- Full Text
- View/download PDF
14. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection
- Author
-
Wong, Yat Yee, Rakasz, Eva G., Gasper, David J., Friedrich, Thomas C., and Trepanier, Lauren A.
- Published
- 2016
- Full Text
- View/download PDF
15. Control of maternal Zika virus infection during pregnancy is associated with lower antibody titers in a macaque model.
- Author
-
Krabbe, Nicholas P., Razo, Elaina, Abraham, Hunter J., Spanton, Rachel V., Yujia Shi, Bhattacharya, Saswati, Bohm, Ellie K., Pritchard, Julia C., Weiler, Andrea M., Mitzey, Ann M., Eickhoff, Jens C., Sullivan, Eric, Tan, John C., Aliota, Matthew T., Friedrich, Thomas C., O'Connor, David H., Golos, Thaddeus G., and Mohr, Emma L.
- Subjects
ZIKA virus infections ,ANTIBODY titer ,ZIKA virus ,ANTIBODY formation ,MACAQUES - Abstract
Introduction: Zika virus (ZIKV) infection during pregnancy results in a spectrum of birth defects and neurodevelopmental deficits in prenatally exposed infants, with no clear understanding of why some pregnancies are more severely affected. Differential control of maternal ZIKV infection may explain the spectrum of adverse outcomes. Methods: Here, we investigated whether the magnitude and breadth of the maternal ZIKV-specific antibody response is associated with better virologic control using a rhesus macaque model of prenatal ZIKV infection. We inoculated 18 dams with an Asian-lineage ZIKV isolate (PRVABC59) at 30-45 gestational days. Plasma vRNA and infectious virus kinetics were determined over the course of pregnancy, as well as vRNA burden in the maternal-fetal interface (MFI) at delivery. Binding and neutralizing antibody assays were performed to determine the magnitude of the ZIKV-specific IgM and IgG antibody responses throughout pregnancy, along with peptide microarray assays to define the breadth of linear ZIKV epitopes recognized. Results: Dams with better virologic control (n= 9) cleared detectable infectious virus and vRNA from the plasma by 7 days post-infection (DPI) and had a lower vRNA burden in the MFI at delivery. In comparison, dams with worse virologic control (n= 9) still cleared detectable infectious virus from the plasma by 7 DPI but had vRNA that persisted longer, and had higher vRNA burden in the MFI at delivery. The magnitudes of the ZIKV-specific antibody responses were significantly lower in the dams with better virologic control, suggesting that higher antibody titers are not associated with better control of ZIKV infection. Additionally, the breadth of the ZIKV linear epitopes recognized did not differ between the dams with better and worse control of ZIKV infection. Discussion: Thus, the magnitude and breadth of the maternal antibody responses do not seem to impact maternal virologic control. This may be because control of maternal infection is determined in the first 7 DPI, when detectable infectious virus is present and before robust antibody responses are generated. However, the presence of higher ZIKV-specific antibody titers in dams with worse virologic control suggests that these could be used as a biomarker of poor maternal control of infection and should be explored further. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Wolbachia-mediated resistance to Zika virus infection in Aedes aegypti is dominated by diverse transcriptional regulation and weak evolutionary pressures.
- Author
-
Boehm, Emma C., Jaeger, Anna S., Ries, Hunter J., Castañeda, David, Weiler, Andrea M., Valencia, Corina C., Weger-Lucarelli, James, Ebel, Gregory D., O'Connor, Shelby L., Friedrich, Thomas C., Zamanian, Mostafa, and Aliota, Matthew T.
- Subjects
ARBOVIRUSES ,ZIKA virus infections ,AEDES aegypti ,GENETIC transcription regulation ,ARBOVIRUS diseases ,DENGUE viruses - Abstract
A promising candidate for arbovirus control and prevention relies on replacing arbovirus-susceptible Aedes aegypti populations with mosquitoes that have been colonized by the intracellular bacterium Wolbachia and thus have a reduced capacity to transmit arboviruses. This reduced capacity to transmit arboviruses is mediated through a phenomenon referred to as pathogen blocking. Pathogen blocking has primarily been proposed as a tool to control dengue virus (DENV) transmission, however it works against a range of viruses, including Zika virus (ZIKV). Despite years of research, the molecular mechanisms underlying pathogen blocking still need to be better understood. Here, we used RNA-seq to characterize mosquito gene transcription dynamics in Ae. aegypti infected with the wMel strain of Wolbachia that are being released by the World Mosquito Program in Medellín, Colombia. Comparative analyses using ZIKV-infected, uninfected tissues, and mosquitoes without Wolbachia revealed that the influence of wMel on mosquito gene transcription is multifactorial. Importantly, because Wolbachia limits, but does not completely prevent, replication of ZIKV and other viruses in coinfected mosquitoes, there is a possibility that these viruses could evolve resistance to pathogen blocking. Therefore, to understand the influence of Wolbachia on within-host ZIKV evolution, we characterized the genetic diversity of molecularly barcoded ZIKV virus populations replicating in Wolbachia-infected mosquitoes and found that within-host ZIKV evolution was subject to weak purifying selection and, unexpectedly, loose anatomical bottlenecks in the presence and absence of Wolbachia. Together, these findings suggest that there is no clear transcriptional profile associated with Wolbachia-mediated ZIKV restriction, and that there is no evidence for ZIKV escape from this restriction in our system. Author summary: When Wolbachia bacteria infect Aedes aegypti mosquitoes, they dramatically reduce the mosquitoes' susceptibility to infection with a range of arthropod-borne viruses, including Zika virus (ZIKV). Although this pathogen-blocking effect has been widely recognized, its mechanisms remain unclear. Furthermore, because Wolbachia limits, but does not completely prevent, replication of ZIKV and other viruses in coinfected mosquitoes, there is a possibility that these viruses could evolve resistance to Wolbachia-mediated blocking. Here, we use host transcriptomics and viral genome sequencing to examine the mechanisms of ZIKV pathogen blocking by Wolbachia and viral evolutionary dynamics in Ae. aegypti mosquitoes. We find complex transcriptome patterns that do not suggest a single clear mechanism for pathogen blocking. We also find no evidence that Wolbachia exerts detectable selective pressures on ZIKV in coinfected mosquitoes. Together our data suggest that it may be difficult for ZIKV to evolve Wolbachia resistance, perhaps due to the complexity of the pathogen blockade mechanism. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection.
- Author
-
Harwood, Olivia E., Matschke, Lea M., Moriarty, Ryan V., Balgeman, Alexis J., Weaver, Abigail J., Ellis-Connell, Amy L., Weiler, Andrea M., Winchester, Lee C., Fletcher, Courtney V., Friedrich, Thomas C., Keele, Brandon F., O'Connor, David H., Lang, Jessica D., Reynolds, Matthew R., and O'Connor, Shelby L.
- Subjects
MACAQUES ,SIMIAN immunodeficiency virus ,RHESUS monkeys ,CD8 antigen ,LYMPHOCYTE subsets ,HIV - Abstract
Sustainable HIV remission after antiretroviral therapy (ART) withdrawal, or post-treatment control (PTC), remains a top priority for HIV treatment. We observed surprising PTC in an MHC-haplomatched cohort of MHC-M3+ SIVmac239+ Mauritian cynomolgus macaques (MCMs) initiated on ART at two weeks post-infection (wpi). None of the MCMs possessed MHC haplotypes previously associated with SIV control. For six months after ART withdrawal, we observed undetectable or transient viremia in seven of the eight MCMs, despite detecting replication competent SIV using quantitative viral outgrowth assays. In vivo depletion of CD8α+ cells induced rebound in all animals, indicating the observed PTC was mediated, at least in part, by CD8α+ cells. With intact proviral DNA assays, we found that MCMs had significantly smaller viral reservoirs two wpi than a cohort of identically infected rhesus macaques, a population that rarely develops PTC. We found a similarly small viral reservoir among six additional SIV+ MCMs in which ART was initiated at eight wpi, some of whom exhibited viral rebound. These results suggest that an unusually small viral reservoir is a hallmark among SIV+ MCMs. By evaluating immunological differences between MCMs that did and did not rebound, we identified that PTC was associated with a reduced frequency of CD4+ and CD8+ lymphocyte subsets expressing exhaustion markers. Together, these results suggest a combination of small reservoirs and immune-mediated virus suppression contribute to PTC in MCMs. Further, defining the immunologic mechanisms that engender PTC in this model may identify therapeutic targets for inducing durable HIV remission in humans. Author summary: The ultimate goal of human immunodeficiency virus (HIV) therapeutic development is to enable HIV+ individuals to stop taking daily lifelong antiretroviral therapeutics (ART) and remain in virological remission, an outcome called post-treatment control. Post-treatment control is challenging to study because it is very rare in humans. Thus, there are currently no therapeutics that lead to post-treatment control. Simian immunodeficiency virus (SIV) in rhesus macaques is the most widely used preclinical model for HIV. However, post-treatment control is also uncommon in rhesus macaques. The mechanisms that govern post-treatment control remain largely unknown because PTC is so rare. Our lab observed surprising post-treatment control in a cohort of Mauritian cynomolgus macaques that were initiated on ART two weeks post-infection. While Mauritian cynomolgus macaques have been used for SIV research, they are not routinely used to study post-treatment control. We found that small viral reservoirs and immune-mediated virus suppression contribute to post-treatment control in Mauritian cynomolgus macaques. Moving forward, this model can be used to further define the mechanisms that engender post-treatment control as well as identify therapeutic targets in humans for inducing durable HIV remission. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. Vertical transmission of African-lineage Zika virus through the fetal membranes in a rhesus macaque (Macaca mulatta) model.
- Author
-
Koenig, Michelle R., Mitzey, Ann M., Zeng, Xiankun, Reyes, Leticia, Simmons, Heather A., Morgan, Terry K., Bohm, Ellie K., Pritchard, Julia C., Schmidt, Jenna A., Ren, Emily, Leyva Jaimes, Fernanda B., Winston, Eva, Basu, Puja, Weiler, Andrea M., Friedrich, Thomas C., Aliota, Matthew T., Mohr, Emma L., and Golos, Thaddeus G.
- Subjects
FETUS ,MACAQUES ,FETAL membranes ,RHESUS monkeys ,ZIKA virus ,AMNIOTIC liquid ,FETAL tissues - Abstract
Zika virus (ZIKV) can be transmitted vertically from mother to fetus during pregnancy, resulting in a range of outcomes including severe birth defects and fetal/infant death. Potential pathways of vertical transmission in utero have been proposed but remain undefined. Identifying the timing and routes of vertical transmission of ZIKV may help us identify when interventions would be most effective. Furthermore, understanding what barriers ZIKV overcomes to effect vertical transmission may help improve models for evaluating infection by other pathogens during pregnancy. To determine the pathways of vertical transmission, we inoculated 12 pregnant rhesus macaques with an African-lineage ZIKV at gestational day 30 (term is 165 days). Eight pregnancies were surgically terminated at either seven or 14 days post-maternal infection. Maternal-fetal interface and fetal tissues and fluids were collected and evaluated for ZIKV using RT-qPCR, in situ hybridization, immunohistochemistry, and plaque assays. Four additional pregnant macaques were inoculated and terminally perfused with 4% paraformaldehyde at three, six, nine, or ten days post-maternal inoculation. For these four cases, the entire fixed pregnant uterus was evaluated with in situ hybridization for ZIKV RNA. We determined that ZIKV can reach the MFI by six days after infection and infect the fetus by ten days. Infection of the chorionic membrane and the extraembryonic coelomic fluid preceded infection of the fetus and the mesenchymal tissue of the placental villi. We did not find evidence to support a transplacental route of ZIKV vertical transmission via infection of syncytiotrophoblasts or villous cytotrophoblasts. The pattern of infection observed in the maternal-fetal interface provides evidence of paraplacental vertical ZIKV transmission through the chorionic membrane, the outer layer of the fetal membranes. Author summary: Zika virus (ZIKV) can be vertically transmitted from mother to fetus during pregnancy resulting in adverse pregnancy outcomes. For vertical transmission to occur, ZIKV must overcome the barriers of the maternal-fetal interface, yet the exact pathway ZIKV takes remains undefined. The maternal-fetal interface consists of the maternal decidua, placenta, chorionic membrane, and amniotic membrane. ZIKV could reach the fetus through the placenta if it infects the layer of cells that are directly exposed to maternal blood. ZIKV could also reach the fetus by infecting the decidua and then the adjacent chorionic membrane. To determine the pathways of ZIKV vertical transmission, we infected pregnant macaques and evaluated ZIKV burden in the maternal-fetal interface and fetus shortly after maternal infection. The pattern of infection observed suggests that ZIKV vertically transmits not through a transplacental route but through a paraplacental route by infecting the chorionic membrane, the outer layer of the fetal membranes. This finding is significant because it challenges the assumption that vertical transmission occurs exclusively across the placenta. Ultimately, this study demonstrates that chorionic membranes are an essential barrier to pathogens that warrant further investigation. By including the chorionic membrane in our models of vertical transmission, we can more accurately determine which pathogens can be vertically transmitted. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Influenza evolution with little host selection
- Author
-
Braun, Katarina M. and Friedrich, Thomas C.
- Published
- 2019
- Full Text
- View/download PDF
20. Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.
- Author
-
Halfmann, Peter J, Minor, Nicholas R, III, Luis A Haddock, Maddox, Robert, Moreno, Gage K, Braun, Katarina M, Baker, David A, Riemersa, Kasen K, Prasad, Ankur, Alman, Kirsten J, Lambert, Matthew C, Florek, Kelsey, Bateman, Allen, Westergaard, Ryan, Safdar, Nasia, Andes, David R, Kawaoka, Yoshihiro, Fida, Madiha, Yao, Joseph D, and Friedrich, Thomas C
- Subjects
SARS-CoV-2 ,IMMUNOCOMPROMISED patients ,MONOCLONAL antibodies ,SARS-CoV-2 Omicron variant - Abstract
Prolonged infections in immunocompromised individuals may be a source for novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants, particularly when both the immune system and antiviral therapy fail to clear the infection and enable within-host evolution. Here we describe a 486-day case of SARS-CoV-2 infection in an immunocompromised individual. Following monotherapy with the monoclonal antibody Bamlanivimab, the individual's virus acquired resistance, likely via the earliest known occurrence of Spike amino acid variant E484T. Recently, E484T has arisen again as a derivative of E484A in the Omicron Variant of Concern, supporting the hypothesis that prolonged infections can give rise to novel variants long before they become prevalent in the human population. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Infection of the maternal-fetal interface and vertical transmission following low-dose inoculation of pregnant rhesus macaques (Macaca mulatta) with an African-lineage Zika virus.
- Author
-
Koenig, Michelle R., Mitzey, Ann M., Morgan, Terry K., Zeng, Xiankun, Simmons, Heather A., Mejia, Andres, Leyva Jaimes, Fernanda, Keding, Logan T., Crooks, Chelsea M., Weiler, Andrea M., Bohm, Ellie K., Aliota, Matthew T., Friedrich, Thomas C., Mohr, Emma L., and Golos, Thaddeus G.
- Subjects
RHESUS monkeys ,ZIKA virus ,MACAQUES ,FETUS ,AMNIOTIC liquid ,FETAL brain ,FETAL membranes - Abstract
Background: Congenital Zika virus (ZIKV) infection can result in birth defects, including malformations in the fetal brain and visual system. There are two distinct genetic lineages of ZIKV: African and Asian. Asian-lineage ZIKVs have been associated with adverse pregnancy outcomes in humans; however, recent evidence from experimental models suggests that African-lineage viruses can also be vertically transmitted and cause fetal harm. Methodology/Principal findings: To evaluate the pathway of vertical transmission of African-lineage ZIKV, we inoculated nine pregnant rhesus macaques (Macaca mulatta) subcutaneously with 44 plaque-forming units of a ZIKV strain from Senegal, (ZIKV-DAK). Dams were inoculated either at gestational day 30 or 45. Following maternal inoculation, pregnancies were surgically terminated seven or 14 days later and fetal and maternal-fetal interface tissues were collected and evaluated. Infection in the dams was evaluated via plasma viremia and neutralizing antibody titers pre- and post- ZIKV inoculation. All dams became productively infected and developed strong neutralizing antibody responses. ZIKV RNA was detected in maternal-fetal interface tissues (placenta, decidua, and fetal membranes) by RT-qPCR and in situ hybridization. In situ hybridization detected ZIKV predominantly in the decidua and revealed that the fetal membranes may play a role in ZIKV vertical transmission. Infectious ZIKV was detected in the amniotic fluid of three pregnancies and one fetus had ZIKV RNA detected in multiple tissues. No significant pathology was observed in any fetus; and ZIKV did not have a substantial effect on the placenta. Conclusions/Significance: This study demonstrates that a very low dose of African-lineage ZIKV can be vertically transmitted to the macaque fetus during pregnancy. The low inoculating dose used in this study suggests a low minimal infectious dose for rhesus macaques. Vertical transmission with a low dose in macaques further supports the high epidemic potential of African ZIKV strains. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Sensitivity of rapid antigen tests for Omicron subvariants of SARS‐CoV‐2.
- Author
-
Sakai‐Tagawa, Yuko, Yamayoshi, Seiya, Halfmann, Peter J., Wilson, Nancy, Bobholz, Max, Vuyk, William C., Wei, Wanting, Ries, Hunter, O'Connor, David H., Friedrich, Thomas C., Sordillo, Emilia M., van Bakel, Harm, Simon, Viviana, and Kawaoka, Yoshihiro
- Subjects
ANTIGEN analysis ,SARS-CoV-2 Omicron variant ,SARS-CoV-2 Delta variant ,SARS-CoV-2 ,DRUGSTORES - Abstract
Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self‐testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID‐19 are based on antibody detection of the SARS‐CoV‐2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS‐CoV‐2 N showed the highest sensitivity followed by Inspecter KOWA SARS‐CoV‐2 and V Trust SARS‐CoV‐2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Reorganization and expansion of the nidoviral family Arteriviridae
- Author
-
Kuhn, Jens H., Lauck, Michael, Bailey, Adam L., Shchetinin, Alexey M., Vishnevskaya, Tatyana V., Bào, Yīmíng, Ng, Terry Fei Fan, LeBreton, Matthew, Schneider, Bradley S., Gillis, Amethyst, Tamoufe, Ubald, Diffo, Joseph Le Doux, Takuo, Jean Michel, Kondov, Nikola O., Coffey, Lark L., Wolfe, Nathan D., Delwart, Eric, Clawson, Anna N., Postnikova, Elena, Bollinger, Laura, Lackemeyer, Matthew G., Radoshitzky, Sheli R., Palacios, Gustavo, Wada, Jiro, Shevtsova, Zinaida V., Jahrling, Peter B., Lapin, Boris A., Deriabin, Petr G., Dunowska, Magdalena, Alkhovsky, Sergey V., Rogers, Jeffrey, Friedrich, Thomas C., O’Connor, David H., and Goldberg, Tony L.
- Published
- 2016
- Full Text
- View/download PDF
24. Co-infection and cross-species transmission of divergent Hepatocystis lineages in a wild African primate community
- Author
-
Thurber, Mary I., Ghai, Ria R., Hyeroba, David, Weny, Geoffrey, Tumukunde, Alex, Chapman, Colin A., Wiseman, Roger W., Dinis, Jorge, Steeil, James, Greiner, Ellis C., Friedrich, Thomas C., O’Connor, David H., and Goldberg, Tony L.
- Published
- 2013
- Full Text
- View/download PDF
25. Influenza Vaccination Is Not Associated With Detection of Noninfluenza Respiratory Viruses in Seasonal Studies of Influenza Vaccine Effectiveness
- Author
-
Sundaram, Maria E., McClure, David L., VanWormer, Jeffrey J., Friedrich, Thomas C., Meece, Jennifer K., and Belongia, Edward A.
- Published
- 2013
- Full Text
- View/download PDF
26. Oropharyngeal mucosal transmission of Zika virus in rhesus macaques
- Author
-
Newman, Christina M., Dudley, Dawn M., Aliota, Matthew T., Weiler, Andrea M., Barry, Gabrielle L., Mohns, Mariel S., Breitbach, Meghan E., Stewart, Laurel M., Buechler, Connor R., Graham, Michael E., Post, Jennifer, Schultz-Darken, Nancy, Peterson, Eric, Newton, Wendy, Mohr, Emma L., Capuano, III, Saverio, O’Connor, David H., and Friedrich, Thomas C.
- Published
- 2017
- Full Text
- View/download PDF
27. Gag- and Nef-Specific CD4⁺ T Cells Recognize and Inhibit SIV Replication in Infected Macrophages Early after Infection
- Author
-
Sacha, Jonah B., Giraldo-Vela, Juan P., Buechler, Matthew B., Martins, Mauricio A., Maness, Nicholas J., Chung, Chungwon, Wallace, Lyle T., León, Enrique J., Friedrich, Thomas C., Wilson, Nancy A., Hiraoka, Atsunobu, Watkins, David I., and Franchini, Genoveffa
- Published
- 2009
- Full Text
- View/download PDF
28. Repeated Intravaginal Inoculation with Cell-Associated Simian Immunodeficiency Virus Results in Persistent Infection of Nonhuman Primates
- Author
-
Kaizu, Masahiko, Weiler, Andrea M., Weisgrau, Kim L., Vielhuber, Kathleen A., May, Gemma, Piaskowski, Shari M., Furlott, Jessica, Maness, Nicholas J., Friedrich, Thomas C., Loffredo, John T., Usborne, Amy, and Rakasz, Eva G.
- Published
- 2006
29. Evidence of Early Household Transmission of SARS-CoV-2 Involving a School-Aged Child
- Author
-
Temte, Jonathan L., Barlow, Shari, Temte, Emily, Goss, Maureen, Florek, Kelsey, Braun, Katrina, Friedrich, Thomas C., Reisdorf, Erik, Bateman, Allen C., and Uzicanin, Amra
- Subjects
Article - Abstract
INTRODUCTION: Little is known about the role of school-aged children and household transmission at the start of the SARS-CoV-2 pandemic. To evaluate for SARS-CoV-2 in school-aged children and assess household transmission, we performed reverse transcription polymerase chain reaction on 670 archived specimens that were collected between September 1, 2019 and June 30, 2020 as part of a community-based study. CASE PRESENTATION: A single SARS-CoV-2 case was detected in an 11-year-old girl on March 18, 2020, resulting in very low prevalence (0.15% [95% CI, 0.03–0.84]) in this population. This case was associated with SARS-CoV-2 detection in all other household members. Symptoms were reported as mild to moderate. Whole genome sequencing supported household transmission of near-identical viruses within the 19B clade. DISCUSSION: This case represents the earliest known household cluster of SARS-CoV2 in Wisconsin. CONCLUSION: This case suggests that household transmission associated with school-aged children may have contributed to wide seeding across populations.
- Published
- 2021
30. Avian H7N9 influenza viruses are evolutionarily constrained by stochastic processes during replication and transmission in mammals.
- Author
-
Braun, Katarina M, Haddock III, Luis A, Crooks, Chelsea M, Barry, Gabrielle L, Lalli, Joseph, Neumann, Gabriele, Watanabe, Tokiko, Imai, Masaki, Yamayoshi, Seiya, Ito, Mutsumi, Moncla, Louise H, Koelle, Katia, Kawaoka, Yoshihiro, and Friedrich, Thomas C
- Subjects
AVIAN influenza A virus ,INFLUENZA A virus, H7N9 subtype ,MAMMAL evolution ,STOCHASTIC processes ,INFLUENZA A virus, H1N1 subtype ,MAMMALS - Abstract
H7N9 avian influenza viruses (AIVs) have caused over 1,500 documented human infections since emerging in 2013. Although wild-type H7N9 AIVs can be transmitted by respiratory droplets in ferrets, they have not yet caused widespread outbreaks in humans. Previous studies have revealed molecular determinants of H7N9 AIV host switching, but little is known about potential evolutionary constraints on this process. Here, we compare patterns of sequence evolution for H7N9 AIV and mammalian H1N1 viruses during replication and transmission in ferrets. We show that three main factors—purifying selection, stochasticity, and very narrow transmission bottlenecks—combine to severely constrain the ability of H7N9 AIV to effectively adapt to mammalian hosts in isolated, acute spillover events. We find rare evidence of natural selection favoring new, potentially mammal-adapting mutations within ferrets but no evidence of natural selection acting during transmission. We conclude that human-adapted H7N9 viruses are unlikely to emerge during typical spillover infections. Our findings are instead consistent with a model in which the emergence of a human-transmissible virus would be a rare and unpredictable, though highly consequential, 'jackpot' event. Strategies to control the total number of spillover infections will limit opportunities for the virus to win this evolutionary lottery. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
31. Anti-membrane Antibodies Persist at Least One Year and Discriminate Between Past Coronavirus Disease 2019 Infection and Vaccination.
- Author
-
Amjadi, Maya F, Adyniec, Ryan R, Gupta, Srishti, Bashar, S Janna, Mergaert, Aisha M, Braun, Katarina M, Moreno, Gage K, O'Connor, David H, Friedrich, Thomas C, Safdar, Nasia, McCoy, Sara S, and Shelef, Miriam A
- Subjects
COVID-19 ,CORONAVIRUS diseases ,IMMUNOGLOBULINS ,VACCINATION ,INFECTION - Abstract
Background: The consequences of past coronavirus disease 2019 (COVID-19) infection for personal and population health are emerging, but accurately identifying distant infection is a challenge. Anti-spike antibodies rise after both vaccination and infection and anti-nucleocapsid antibodies rapidly decline.Methods: We evaluated anti-membrane antibodies in COVID-19 naive, vaccinated, and convalescent subjects to determine if they persist and accurately detect distant infection.Results: We found that anti-membrane antibodies persist for at least 1 year and are a sensitive and specific marker of past COVID-19 infection.Conclusions: Thus, anti-membrane and anti-spike antibodies together can differentiate between COVID-19 convalescent, vaccinated, and naive states to advance public health and research. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
32. Naturally circulating hepatitis a virus in Olive Baboons, Uganda
- Author
-
Bennett, Andrew J., Sibley, Samuel D., Lauck, Michael, Weny, Geoffrey, Hyeroba, David, Tumukunde, Alex, Friedrich, Thomas C., O'Connor, David H., Johnson, Caley A., Rothman, Jessica M., and Goldberg, Tony L.
- Subjects
Hepatitis A -- Distribution ,Baboons -- Health aspects ,Zoonoses -- Distribution ,Company distribution practices ,Health - Abstract
To the Editor: Hepatitis A (HAV; family Picornaviridae; genus Hepatovirus) is an ≅ 7.5-kb single-stranded positive-sense RNA virus that causes acute inflammation of the liver in humans and nonhuman primates. [...]
- Published
- 2016
33. Shedding of infectious SARS-CoV-2 despite vaccination.
- Author
-
Riemersma, Kasen K., Haddock III, Luis A., Wilson, Nancy A., Minor, Nicholas, Eickhoff, Jens, Grogan, Brittany E., Kita-Yarbro, Amanda, Halfmann, Peter J., Segaloff, Hannah E., Kocharian, Anna, Florek, Kelsey R., Westergaard, Ryan, Bateman, Allen, Jeppson, Gunnar E., Kawaoka, Yoshihiro, O'Connor, David H., Friedrich, Thomas C., and Grande, Katarina M.
- Subjects
SARS-CoV-2 Delta variant ,SARS-CoV-2 ,VACCINATION status ,VACCINATION ,HEALTH policy - Abstract
The SARS-CoV-2 Delta Variant of Concern is highly transmissible and contains mutations that confer partial immune escape. The emergence of Delta in North America caused the first surge in COVID-19 cases after SARS-CoV-2 vaccines became widely available. To determine whether individuals infected despite vaccination might be capable of transmitting SARS-CoV-2, we compared RT-PCR cycle threshold (Ct) data from 20,431 test-positive anterior nasal swab specimens from fully vaccinated (n = 9,347) or unvaccinated (n = 11,084) individuals tested at a single commercial laboratory during the interval 28 June– 1 December 2021 when Delta variants were predominant. We observed no significant effect of vaccine status alone on Ct value, nor when controlling for vaccine product or sex. Testing a subset of low-Ct (<25) samples, we detected infectious virus at similar rates, and at similar titers, in specimens from vaccinated and unvaccinated individuals. These data indicate that vaccinated individuals infected with Delta variants are capable of shedding infectious SARS-CoV-2 and could play a role in spreading COVID-19. Author summary: A pivotal moment in the COVID-19 pandemic in the U.S. occurred during the summer of 2021—after the majority of people were vaccinated against the virus that causes COVID. The paradigm at the time was that infection and transmission after vaccination were rare. After contact tracers noticed an increase in infections after vaccination, we rapidly assembled a team of virologists, epidemiologists, and public health officials to investigate. Our study was conducted in Wisconsin at a time when the Delta variant accounted for almost all new infections. While data related to individual outbreaks and large gatherings were emerging, we examined data from community test sites spread over a wide geographic area in Wisconsin. We found that a large proportion of people with infection despite full vaccination had high levels of virus in their bodies, regardless of sex or the type of vaccine they received. Our study was one of the first to demonstrate the possibility that vaccinated people could play a role in spreading COVID, and helped inform public health policies (such as mask mandates) to cope with new surges in COVID-19 cases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. Reversion of CTL escape–variant immunodeficiency viruses in vivo
- Author
-
Friedrich, Thomas C, Dodds, Elizabeth J, Yant, Levi J, Vojnov, Lara, Rudersdorf, Richard, Cullen, Candice, Evans, David T, Desrosiers, Ronald C, Mothé, Bianca R, Sidney, John, Sette, Alessandro, Kunstman, Kevin, Wolinsky, Steven, Piatak, Michael, Lifson, Jeffrey, Hughes, Austin L, Wilson, Nancy, O'Connor, David H, and Watkins, David I
- Published
- 2004
- Full Text
- View/download PDF
35. An outbreak of the 2009 influenza a (H1N1) virus in a children’s hospital
- Author
-
Bearden, Allison, Friedrich, Thomas C., Goldberg, Tony L., Byrne, Barbara, Spiegel, Carol, Schult, Peter, and Safdar, Nasia
- Published
- 2012
- Full Text
- View/download PDF
36. CREATION OF GENOME-WIDE CD8+ T CELL EPITOPE KNOCKOUT SIV VIRUSES FOR MAURITIAN CYNOMOLGUS MACAQUES: Abstract #81
- Author
-
OʼConnor, Shelby L., Burns, Charles M., Friedrich, Thomas C., Broman, Karl W., Kallas, Esper G., and OʼConnor, & David H.
- Published
- 2011
37. The mucosal barrier and anti-viral immune responses can eliminate portions of the viral population during transmission and early viral growth.
- Author
-
Moriarty, Ryan V., Golfinos, Athena E., Gellerup, Dane D., Schweigert, Hannah, Mathiaparanam, Jaffna, Balgeman, Alexis J., Weiler, Andrea M., Friedrich, Thomas C., Keele, Brandon F., Davenport, Miles P., Venturi, Vanessa, and O'Connor, Shelby L.
- Subjects
SIMIAN immunodeficiency virus ,VIRAL transmission ,KRA ,RHESUS monkeys ,HIV - Abstract
Little is known about how specific individual viral lineages replicating systemically during acute Human Immunodeficiency Virus or Simian Immunodeficiency Virus (HIV/SIV) infection persist into chronic infection. In this study, we use molecularly barcoded SIV (SIVmac239M) to track distinct viral lineages for 12 weeks after intravenous (IV) or intrarectal (IR) challenge in macaques. Two Mafa-A1*063+ cynomolgus macaques (Macaca fascicularis, CM) were challenged IV, and two Mamu-A1*001+ rhesus macaques (Macaca mulatta, RM) were challenged IR with 200,000 Infectious Units (IU) of SIVmac239M. We sequenced the molecular barcode of SIVmac239M from all animals over the 12 weeks of the study to characterize the diversity and persistence of virus lineages. During the first three weeks post-infection, we found ~70–560 times more unique viral lineages circulating in the animals challenged IV compared to those challenged IR, which is consistent with the hypothesis that the challenge route is the primary driver restricting the transmission of individual viral lineages. We also characterized the sequences of T cell epitopes targeted during acute SIV infection, and found that the emergence of escape variants in acutely targeted epitopes can occur on multiple virus templates simultaneously, but that elimination of some of these templates is likely a consequence of additional host factors. These data imply that virus lineages present during acute infection can still be eliminated from the systemic virus population even after initial selection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
38. SARS-CoV-2 Genomic Surveillance Reveals Little Spread From a Large University Campus to the Surrounding Community.
- Author
-
Valesano, Andrew L, Fitzsimmons, William J, Blair, Christopher N, Woods, Robert J, Gilbert, Julie, Rudnik, Dawn, Mortenson, Lindsey, Friedrich, Thomas C, O'Connor, David H, MacCannell, Duncan R, Petrie, Joshua G, Martin, Emily T, and Lauring, Adam S
- Subjects
COVID-19 ,SARS-CoV-2 ,INFECTIOUS disease transmission - Abstract
Background Coronavirus disease 2019 (COVID-19) has had high incidence rates at institutions of higher education (IHE) in the United States, but the transmission dynamics in these settings are poorly understood. It remains unclear to what extent IHE-associated outbreaks have contributed to transmission in nearby communities. Methods We implemented high-density prospective genomic surveillance to investigate these dynamics at the University of Michigan and the surrounding community during the Fall 2020 semester (August 16–November 24). We sequenced complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from 1659 individuals, including 468 students, representing 20% of cases in students and 25% of total cases in Washtenaw County over the study interval. Results Phylogenetic analysis identified >200 introductions into the student population, most of which were not related to other student cases. There were 2 prolonged student transmission clusters, of 115 and 73 individuals, that spanned multiple on-campus residences. Remarkably, <5% of nonstudent genomes were descended from student clusters, and viral descendants of student cases were rare during a subsequent wave of infections in the community. Conclusions The largest outbreaks among students at the University of Michigan did not significantly contribute to the rise in community cases in Fall 2020. These results provide valuable insights into SARS-CoV-2 transmission dynamics at the regional level. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Pharyngeal motor cortex grey matter abnormalities and retinal photoreceptor layer dysfunction in macaques exposed to Zika virus in utero
- Author
-
Koenig, Michelle R., Razo, Elaina, Mitzey, Ann, Semler, Matthew R., Stewart, Laurel M., Breitbach, Meghan E., Newman, Christina M., Dudley, Dawn M., Weiler, Andrea M., Rybarczyk, Sierra, Bach, Kathryn M., Mohns, Mariel S., Simmons, Heather A., Mejia, Andres, Dennis, Maria, Teixeira, Leandro B. C., Schotzko, Michele L., Nork, T. Michael, Rasmussen, Carol A., Katz, Alex, Hou, Jiancheng, Hartman, Amy, Ver Hoeve, James, Kim, Charlene, Schneider, Mary L., Ausderau, Karla, Kohn, Sarah, Jaeger, Anna S., Aliota, Matthew T., Salamat, M. Shahriar, Hayes, Jennifer M., Schultz-Darken, Nancy, Eickhoff, Jens, Antony, Kathleen M., Noguchi, Kevin, Zeng, Xiankun, Permar, Sallie, Ikonomidou, Chrysanthy, Prabhakaran, Vivek, Capuano III, Saverio, Friedrich, Thomas C., Golos, Thaddeus G., O’Connor, David H., and Mohr, Emma L.
- Abstract
One third of infants who have prenatal Zika virus (ZIKV) exposure and lack significant defects consistent with congenital Zika syndrome (CZS) manifest neurodevelopmental deficits in their second year of life. We hypothesized that prenatal ZIKV exposure would lead to brain abnormalities and neurodevelopmental delays in infant macaques, as measured by quantitative hearing, neurodevelopmental, ocular and brain imaging studies. We inoculated 5 pregnant rhesus macaques with ZIKV during the first trimester, monitored pregnancies with serial ultrasounds, determined plasma viral RNA (vRNA) loads, and evaluated the infants for birth defects and neurodevelopmental deficits during their first week of life. ZIKV-exposed and control infants (n=16) were evaluated with neurobehavioral assessments, ophthalmic examinations, optical coherence tomography, electroretinography with visual evoked potentials, hearing examinations, magnetic resonance imaging (MRI) of the brain, gross post mortem examination, and histopathological and vRNA analyses of approximately 40 tissues and fluids. All 5 dams had ZIKV vRNA in plasma and seroconverted following ZIKV inoculation. One pregnancy resulted in a stillbirth. The ZIKV-exposed infants had decreased cumulative feeding volumes and weight gains compared with control infants, and also had grey matter abnormalities in the pharyngeal motor cortex identified by quantitative voxel-based morphometric comparisons. Quantitative ocular studies identified differences between ZIKV-exposed and control infants in retinal layer thicknesses and electroretinograms that were not identified in qualitative ophthalmic evaluations. Despite these findings of neuropathology, no ZIKV vRNA or IgM was detected in the infants. This suggests that ZIKV exposure without measurable vertical transmission can affect brain development in utero and that subtle neurodevelopmental delays may be detected with quantitative analyses in early infancy. Quantitative brain analyses, such as these, may predict neurodevelopmental delays that manifest later in childhood and allow early intervention and targeted therapies to improve functional outcomes of ZIKV exposed children. Author Summary Human infants with born to women with Zika virus infection during pregnancy are at risk for neurodevelopmental deficits later in childhood. We hypothesized that we could identify brain abnormalities associated with neurodevelopmental deficits in infant macaques exposed to Zika virus during pregnancy. We identified brain and retinal abnormalities in Zika virus-exposed infant macaques during their first week of life, which may be related to their findings of decreased feeding and slower weight gain. None of the infants had direct evidence of Zika virus infection in their tissues, body fluids or by detection of IgM antibodies. This suggests that Zika virus exposure during pregnancy can affect brain development in utero and that quantitative brain imaging analyses may predict neurodevelopmental delays. Early identification of Zika virus-exposed children at risk of neurodevelopmental deficits would promote targeted therapies in this population and improve the functional outcome of all Zika virus exposed children.
- Published
- 2019
- Full Text
- View/download PDF
40. Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses
- Author
-
Wilker, Peter R., Dinis, Jorge M., Starrett, Gabriel, Imai, Masaki, Hatta, Masato, Nelson, Chase W., O’Connor, David H., Hughes, Austin L., Neumann, Gabriele, Kawaoka, Yoshihiro, and Friedrich, Thomas C.
- Published
- 2013
- Full Text
- View/download PDF
41. Viral Sequencing to Investigate Sources of SARS-CoV-2 Infection in US Healthcare Personnel.
- Author
-
Braun, Katarina M, Moreno, Gage K, Buys, Ashley, Somsen, Elizabeth D, Bobholz, Max, Accola, Molly A, Anderson, Laura, Rehrauer, William M, Baker, David A, Safdar, Nasia, Lepak, Alexander J, O'Connor, David H, and Friedrich, Thomas C
- Subjects
COVID-19 ,SEQUENCE analysis ,ACQUISITION of data methodology ,ACADEMIC medical centers ,PREVENTION of communicable diseases ,CROSS infection ,RETROSPECTIVE studies ,INTERVIEWING ,RISK assessment ,MEDICAL records ,CASE studies ,GENOMICS ,INFECTIOUS disease transmission - Abstract
Background Healthcare personnel (HCP) are at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We posit that current infection control guidelines generally protect HCP from SARS-CoV-2 infection in a healthcare setting. Methods In this retrospective case series, we used viral genomics to investigate the likely source of SARS-CoV-2 infection in HCP at a major academic medical institution in the Upper Midwest of the United States between 25 March and 27 December 2020. We obtained limited epidemiological data through informal interviews and review of the electronic health record and combined this information with healthcare-associated viral sequences and viral sequences collected in the broader community to infer the most likely source of infection in HCP. Results We investigated SARS-CoV-2 infection clusters involving 95 HCP and 137 possible patient contact sequences. The majority of HCP infections could not be linked to a patient or coworker (55 of 95 [57.9%]) and were genetically similar to viruses circulating concurrently in the community. We found that 10.5% of HCP infections (10 of 95) could be traced to a coworker. Strikingly, only 4.2% (4 of 95) could be traced to a patient source. Conclusions Infections among HCP add further strain to the healthcare system and put patients, HCP, and communities at risk. We found no evidence for healthcare-associated transmission in the majority of HCP infections evaluated. Although we cannot rule out the possibility of cryptic healthcare-associated transmission, it appears that HCP most commonly become infected with SARS-CoV-2 via community exposure. This emphasizes the ongoing importance of mask wearing, physical distancing, robust testing programs, and rapid distribution of vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
42. Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks.
- Author
-
Braun, Katarina M., Moreno, Gage K., Wagner, Cassia, Accola, Molly A., Rehrauer, William M., Baker, David A., Koelle, Katia, O'Connor, David H., Bedford, Trevor, Friedrich, Thomas C., and Moncla, Louise H.
- Subjects
SARS-CoV-2 ,SINGLE nucleotide polymorphisms ,GENETIC variation ,LONG-Term Evolution (Telecommunications) ,VIRUS diversity - Abstract
The emergence of divergent SARS-CoV-2 lineages has raised concern that novel variants eliciting immune escape or the ability to displace circulating lineages could emerge within individual hosts. Though growing evidence suggests that novel variants arise during prolonged infections, most infections are acute. Understanding how efficiently variants emerge and transmit among acutely-infected hosts is therefore critical for predicting the pace of long-term SARS-CoV-2 evolution. To characterize how within-host diversity is generated and propagated, we combine extensive laboratory and bioinformatic controls with metrics of within- and between-host diversity to 133 SARS-CoV-2 genomes from acutely-infected individuals. We find that within-host diversity is low and transmission bottlenecks are narrow, with very few viruses founding most infections. Within-host variants are rarely transmitted, even among individuals within the same household, and are rarely detected along phylogenetically linked infections in the broader community. These findings suggest that most variation generated within-host is lost during transmission. Author summary: RNA viruses generate diversity within individual, infected hosts. This genetic diversity can be used to trace how viruses evolve during the course of infection within individuals, and transmission between them. To investigate how SARS-CoV-2 diversity is generated and propagated, we deep sequenced 133 SARS-CoV-2 genomes isolated from acutely infected individuals in Wisconsin. We capitalize on a large dataset of consensus genomes from Wisconsin to investigate how variants are transmitted within the surrounding community, and use a unique household dataset to estimate the number of viruses that are transmitted between epidemiologically linked individuals. We find that most SARS-CoV-2 infections are characterized by limited within-host diversity, and that the vast majority of intra-host single nucleotide variants (iSNVs) are lost during transmission. We do not find evidence that variation is frequently propagated along phylogenetically linked infections, and estimate that most infections are founded by very few unique virions. The combination of limited within-host diversity and tight transmission bottlenecks may slow the pace of SARS-CoV-2 evolution in the future, and suggests that extensive within-host evolution is likely rare. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Intercollegiate Athletics Not Fully Mitigated With Daily Antigen Testing.
- Author
-
Moreno, Gage K, Braun, Katarina M, Pray, Ian W, Segaloff, Hannah E, Lim, Ailam, Poulsen, Keith, Meiman, Jonathan, Borcher, James, Westergaard, Ryan P, Moll, Michael K, Friedrich, Thomas C, and O'Connor, David H
- Subjects
VIRAL antigens ,REVERSE transcriptase polymerase chain reaction ,COVID-19 ,SEQUENCE analysis ,FLUOROIMMUNOASSAY ,QUARANTINE ,SCHOOL administrators ,COLLEGE sports ,RISK assessment ,INFECTIOUS disease transmission ,DESCRIPTIVE statistics ,POLYMERASE chain reaction ,DISEASE risk factors - Abstract
Background High-frequency, rapid-turnaround severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, 2 SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester, despite mandatory directly observed daily antigen testing. Methods During the fall 2020 semester, athletes and staff in both programs were tested daily using Quidel's Sofia SARS Antigen Fluorescent Immunoassay, with positive antigen results requiring confirmatory testing with real-time reverse-transcription polymerase chain reaction. We used genomic sequencing to investigate transmission dynamics in these 2 outbreaks. Results In the first outbreak, 32 confirmed cases occurred within a university athletics program after the index patient attended a meeting while infectious, despite a negative antigen test on the day of the meeting. Among isolates sequenced from that outbreak, 24 (92%) of 26 were closely related, suggesting sustained transmission following an initial introduction event. In the second outbreak, 12 confirmed cases occurred among athletes from 2 university programs that faced each other in an athletic competition, despite receipt of negative antigen test results on the day of the competition. Sequences from both teams were closely related and distinct from viruses circulating in the community for team 1, suggesting transmission during intercollegiate competition in the community for team 2. Conclusions These findings suggest that antigen testing alone, even when mandated and directly observed, may not be sufficient as an intervention to prevent SARS-CoV-2 outbreaks in congregate settings, and they highlight the importance of vaccination to prevent SARS-CoV-2 outbreak in congregate settings. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
44. Early Embryonic Loss Following Intravaginal Zika Virus Challenge in Rhesus Macaques.
- Author
-
Newman, Christina M., Tarantal, Alice F., Martinez, Michele L., Simmons, Heather A., Morgan, Terry K., Zeng, Xiankun, Rosinski, Jenna R., Bliss, Mason I., Bohm, Ellie K., Dudley, Dawn M., Aliota, Matthew T., Friedrich, Thomas C., Miller, Christopher J., and O'Connor, David H.
- Subjects
RHESUS monkeys ,ZIKA virus ,PREGNANCY outcomes ,FETAL tissues ,ARBOVIRUSES - Abstract
Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) and is primarily transmitted by Aedes species mosquitoes; however, ZIKV can also be sexually transmitted. During the initial epidemic and in places where ZIKV is now considered endemic, it is difficult to disentangle the risks and contributions of sexual versus vector-borne transmission to adverse pregnancy outcomes. To examine the potential impact of sexual transmission of ZIKV on pregnancy outcome, we challenged three rhesus macaques (Macaca mulatta) three times intravaginally with 1 x 10
7 PFU of a low passage, African lineage ZIKV isolate (ZIKV-DAK) in the first trimester (~30 days gestational age). Samples were collected from all animals initially on days 3 through 10 post challenge, followed by twice, and then once weekly sample collection; ultrasound examinations were performed every 3-4 days then weekly as pregnancies progressed. All three dams had ZIKV RNA detectable in plasma on day 3 post-ZIKV challenge. At approximately 45 days gestation (17-18 days post-challenge), two of the three dams were found with nonviable embryos by ultrasound. Viral RNA was detected in recovered tissues and at the maternal-fetal interface (MFI) in both cases. The remaining viable pregnancy proceeded to near term (~155 days gestational age) and ZIKV RNA was detected at the MFI but not in fetal tissues. These results suggest that sexual transmission of ZIKV may represent an underappreciated risk of pregnancy loss during early gestation. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
45. Pre-existing SIV Infection Increases Susceptibility to Tuberculosis in Mauritian Cynomolgus Macaques
- Author
-
Rodgers, Mark A., Ameel, Cassaundra, Ellis-Connell, Amy L., Balgeman, Alexis J., Maiello, Pauline, Barry, Gabrielle L., Friedrich, Thomas C., Klein, Edwin, O’Connor, Shelby L., and Scanga, Charles A.
- Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis ( M.tb ), is the leading cause of death among HIV positive patients. The precise mechanisms by which HIV impairs host resistance to a subsequent M.tb infection are unknown. We modeled this co-infection in Mauritian cynomolgus macaques (MCM) using SIV as an HIV surrogate. We infected seven MCM with SIVmac239 intrarectally and six months later co-infected them via bronchoscope with ~10 CFU M.tb . Another eight MCM were infected with M.tb alone. TB progression was monitored by clinical parameters, by culturing bacilli in gastric and bronchoalveolar lavages, and by serial 18 F-FDG PET/CT imaging. The eight MCM infected with M.tb alone displayed dichotomous susceptibility to TB, with four animals reaching humane endpoint within 13 weeks and four animals surviving >19 weeks post M.tb infection. In stark contrast, all seven SIV+ animals exhibited rapidly progressive TB following co-infection and all reached humane endpoint by 13 weeks. Serial PET/CT imaging confirmed dichotomous outcomes in MCM infected with M.tb alone and marked susceptibility to TB in all SIV+ MCM. Notably, imaging revealed a significant increase in TB granulomas between four and eight weeks post M.tb infection in SIV+, but not in SIV-naive MCM and implies that SIV impairs the ability of animals to contain M.tb dissemination. At necropsy, animals with pre-existing SIV infection had more extrapulmonary TB disease, more overall pathology, and increased bacterial loads than animals infected with M.tb alone. We thus developed a tractable MCM model in which to study SIV- M.tb co-infection and demonstrate that pre-existing SIV dramatically diminishes the ability to control M.tb co-infection. Author summary Mycobacterium tuberculosis ( M.tb ) is the etiologic agent of tuberculosis (TB) and infects a tremendous number of individuals. TB causes millions of deaths each year and is the leading cause of death in human immunodeficiency virus (HIV)-positive individuals. Currently, the mechanisms by which pre-existing HIV infection increases susceptibility to subsequent M.tb infection and predisposes an individual to TB disease are poorly understood. We developed a simian immunodeficiency virus (SIV) - M.tb co-infection model in Mauritian cynomolgus macaques (MCM) to investigate how SIV impairs the immune response to a subsequent M.tb infection. We show that naive MCM display variable resistance to TB while all SIV-infected MCM failed to control M.tb infection. Using quantitative measures of disease and serial PET/CT imaging, we show that SIV+ co-infected animals uniformly exhibit rapid TB progression, more tuberculosis disease dissemination, and increased mortality. This coinfection model will facilitate studies, provide unique insights into the defects underlying TB susceptibility in HIV+ individuals and will help us develop approaches to overcome these defects.
- Published
- 2018
- Full Text
- View/download PDF
46. Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primates.
- Author
-
Hangartner, Lars, Beauparlant, David, Rakasz, Eva, Nedellec, Rebecca, Hozé, Nathanaël, McKenney, Katherine, Martins, Mauricio A., Seabright, Gemma E., Allen, Joel D., Weiler, Andrea M., Friedrich, Thomas C., Regoes, Roland R., Crispin, Max, and Burton, Dennis R.
- Subjects
HIV ,FC receptors ,SIMIAN immunodeficiency virus ,IMMUNOGLOBULINS ,PRIMATES ,CELL physiology ,VIRUSES - Abstract
Fc function in focus: There are multiple mechanisms by which broadly neutralizing antibodies (bnAbs) promote protection against HIV, including neutralization of virions and Fc receptor–mediated induction of effector functions on immune cells. Here, Hangartner et al. used variants of the potent HIV bnAb, PGT121, to investigate whether Fc receptor function is required for the protective effects elicited by antibody treatment. The authors showed that variants of PGT121 that could not bind to Fc receptors still protected female macaques against intravaginal simian-HIV infection. These findings underpin the importance of neutralization in determining effectiveness of bnAb treatment for HIV. Protection from immunodeficiency virus challenge in nonhuman primates (NHPs) by a first-generation HIV broadly neutralizing antibody (bnAb) b12 has previously been shown to benefit from interaction between the bnAb and Fcγ receptors (FcγRs) on immune cells. To investigate the mechanism of protection for a more potent second-generation bnAb currently in clinical trials, PGT121, we carried out a series of NHP studies. These studies included treating with PGT121 at a concentration at which only half of the animals were protected to avoid potential masking of FcγR effector function benefits by dominant neutralization and using a new variant that more completely eliminated all rhesus FcγR binding than earlier variants. In contrast to b12, which required FcγR binding for optimal protection, we concluded that PGT121-mediated protection is not augmented by FcγR interaction. Thus, for HIV-passive antibody prophylaxis, these results, together with existing literature, emphasize the importance of neutralization potency for clinical antibodies, with effector function requiring evaluation for individual antibodies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
47. Immunophenotyping of Rhesus CMV‐Specific CD8 T‐Cell Populations.
- Author
-
Pomplun, Nicholas L., Vosler, Logan, Weisgrau, Kim L., Furlott, Jessica, Weiler, Andrea M., Abdelaal, Hadia M., Evans, David T., Watkins, David I., Matano, Tetsuro, Skinner, Pamela J., Friedrich, Thomas C., and Rakasz, Eva G.
- Abstract
A vaccine to ameliorate cytomegalovirus (CMV)‐related pathogenicity in transplantation patients is considered a top priority. A therapeutic vaccine must include components that elicit both neutralizing antibodies, and highly effective CD8 T‐cell responses. The most important translational model of vaccine development is the captive‐bred rhesus macaque (Macaca mulatta) of Indian origin. There is a dearth of information on rhesus cytomegalovirus (rhCMV)‐specific CD8 T cells due to the absence of well‐defined CD8 T‐cell epitopes presented by classical MHC‐I molecules. In the current study, we defined two CD8 T‐cell epitopes restricted by high‐frequency Mamu alleles: the Mamu‐A1*002:01 restricted VY9 (VTTLGMALY aa291‐299) epitope of protein IE‐1, and the Mamu‐A1*008:01 restricted NP8 (NPTDRPIP aa96‐103) epitope of protein phosphoprotein 65‐2. We developed tetramers and determined the level, phenotype, and functional capability of the two epitope‐specific T‐cell populations in circulation and various tissues. We demonstrated the value of these tetramers for in situ tetramer staining. Here, we first provided critical reagents and established a flow cytometric staining strategy to study rhCMV‐specific T‐cell responses in up to 40% of captive‐bred rhesus macaques. © 2020 The Authors. Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
48. Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck.
- Author
-
Braun, Katarina M., Moreno, Gage K., Halfmann, Peter J., Hodcroft, Emma B., Baker, David A., Boehm, Emma C., Weiler, Andrea M., Haj, Amelia K., Hatta, Masato, Chiba, Shiho, Maemura, Tadashi, Kawaoka, Yoshihiro, Koelle, Katia, O'Connor, David H., and Friedrich, Thomas C.
- Subjects
CATS ,SARS-CoV-2 ,GENETIC drift ,RNA viruses ,STOCHASTIC processes ,FELIDAE - Abstract
The evolutionary mechanisms by which SARS-CoV-2 viruses adapt to mammalian hosts and, potentially, undergo antigenic evolution depend on the ways genetic variation is generated and selected within and between individual hosts. Using domestic cats as a model, we show that SARS-CoV-2 consensus sequences remain largely unchanged over time within hosts, while dynamic sub-consensus diversity reveals processes of genetic drift and weak purifying selection. We further identify a notable variant at amino acid position 655 in Spike (H655Y), which was previously shown to confer escape from human monoclonal antibodies. This variant arises rapidly and persists at intermediate frequencies in index cats. It also becomes fixed following transmission in two of three pairs. These dynamics suggest this site may be under positive selection in this system and illustrate how a variant can quickly arise and become fixed in parallel across multiple transmission pairs. Transmission of SARS-CoV-2 in cats involved a narrow bottleneck, with new infections founded by fewer than ten viruses. In RNA virus evolution, stochastic processes like narrow transmission bottlenecks and genetic drift typically act to constrain the overall pace of adaptive evolution. Our data suggest that here, positive selection in index cats followed by a narrow transmission bottleneck may have instead accelerated the fixation of S H655Y, a potentially beneficial SARS-CoV-2 variant. Overall, our study suggests species- and context-specific adaptations are likely to continue to emerge. This underscores the importance of continued genomic surveillance for new SARS-CoV-2 variants as well as heightened scrutiny for signatures of SARS-CoV-2 positive selection in humans and mammalian model systems. Author summary: Through ongoing human adaptation, spill-back events from other animal intermediates, or with the distribution of vaccines and therapeutics, the landscape of SARS-CoV-2 genetic variation is certain to change. The evolutionary mechanisms by which SARS-CoV-2 will continue to adapt to mammalian hosts depend on genetic variation generated within and between hosts. Here, using domestic cats as a model, we show that within-host SARS-CoV-2 genetic variation is predominantly influenced by genetic drift and purifying selection. Transmission of SARS-CoV-2 between hosts is defined by a narrow transmission bottleneck, involving 2–5 viruses. We further identify a notable variant at amino acid position 655 in Spike (H655Y), which arises rapidly and is transmitted in cats. Spike H655Y has been previously shown to confer escape from human monoclonal antibodies and is currently found in over 1000 human sequences. Overall, our study suggests species- and context-specific adaptations are likely to continue to emerge, underscoring the importance of continued genomic surveillance in humans and non-human mammalian hosts. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
49. Optimizing direct RT-LAMP to detect transmissible SARS-CoV-2 from primary nasopharyngeal swab samples.
- Author
-
Dudley, Dawn M., Newman, Christina M., Weiler, Andrea M., Ramuta, Mitchell D., Shortreed, Cecilia G., Heffron, Anna S., Accola, Molly A., Rehrauer, William M., Friedrich, Thomas C., and O'Connor, David H.
- Subjects
SARS-CoV-2 ,REVERSE transcriptase ,COVID-19 ,NUCLEIC acids ,VIRAL transmission ,DETECTION limit - Abstract
SARS-CoV-2 testing is crucial to controlling the spread of this virus, yet shortages of nucleic acid extraction supplies and other key reagents have hindered the response to COVID-19 in the US. Several groups have described loop-mediated isothermal amplification (LAMP) assays for SARS-CoV-2, including testing directly from nasopharyngeal swabs and eliminating the need for reagents in short supply. Frequent surveillance of individuals attending work or school is currently unavailable to most people but will likely be necessary to reduce the ~50% of transmission that occurs when individuals are nonsymptomatic. Here we describe a fluorescence-based RT-LAMP test using direct nasopharyngeal swab samples and show consistent detection in clinically confirmed primary samples with a limit of detection (LOD) of ~625 copies/μl, approximately 100-fold lower sensitivity than qRT-PCR. While less sensitive than extraction-based molecular methods, RT-LAMP without RNA extraction is fast and inexpensive. Here we also demonstrate that adding a lysis buffer directly into the RT-LAMP reaction improves the sensitivity of some samples by approximately 10-fold. Furthermore, purified RNA in this assay achieves a similar LOD to qRT-PCR. These results indicate that high-throughput RT-LAMP testing could augment qRT-PCR in SARS-CoV-2 surveillance programs, especially while the availability of qRT-PCR testing and RNA extraction reagents is constrained. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
50. Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013–2014 Through 2015–2016.
- Author
-
McLean, Huong Q, King, Jennifer P, Talley, Pamela, Flannery, Brendan, Spencer, Sarah, Levine, Min Z, Friedrich, Thomas C, and Belongia, Edward A
- Subjects
HEMAGGLUTINATION tests ,INFLUENZA vaccines ,SEASONS ,VIRAL antibodies ,VIRAL antigens ,SEASONAL influenza ,ANTIBODY formation ,CHILDREN - Abstract
Background The effects of repeated influenza vaccination in children are not well understood. In this study, we evaluated previous vaccination effects on antibody response after vaccination with trivalent inactivated influenza vaccine (IIV) or quadrivalent live-attenuated influenza vaccine (LAIV) among school-aged children (5–17 years) across 3 seasons. Methods Children were enrolled in the fall of 2013, 2014, and 2015. The participants received IIV or LAIV according to parent preference (2013–2014) or our randomization scheme (2014–2015). All study children received IIV in 2015–2016. Hemagglutination-inhibition assays measured antibody response to egg-grown vaccine strains from prevaccination and postvaccination serum samples. Geometric mean titers (GMTs) and increases in GMTs from before to after vaccination (geometric mean fold rise [GMFR]) were estimated from repeated-measures linear mixed models. Results We enrolled 161 children in 2013–2014, 128 in 2014–2015, and 126 in 2015–2016. Among the IIV recipients, responses to the influenza A(H1N1)pdm09 and B vaccine strains were lowest among children who had received a previous-season IIV. The GMFRs for strains A(H1N1)pdm09 and B were 1.5 to 2.3 for previous-season IIV and 4.3 to 12.9 for previous-season LAIV or no previous vaccine. GMFRs were lower for strain A(H3N2), and differences according to previous-season vaccination history were smaller and not significant in most seasons. Most children had a post-IIV vaccination titer of ≥40 for vaccine strains in all seasons, regardless of previous-season vaccination history. Little to no increase in antibody levels was observed after vaccination with LAIV. Conclusions Serologic response to vaccination was greatest for IIV, but previous-season vaccination modified IIV response to A(H1N1)pdm09 and B. Influenza A(H3N2) responses were low in all groups, and LAIV generated minimal serologic response against all strains. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.